Abstract
A compartmentalized mathematical model of transgenic (TG) mouse ventricular myocytes overexpressing adenylyl cyclase type 5 was developed. The model describes well β1- and β2-adrenergic signaling systems consisting of β1- and β2-adrenergic receptors (β1-ARs and β2-ARs), stimulatory and inhibitory G proteins (Gs and Gi), adenylyl cyclases types 4–7 (AC4–7), phosphodiesterases type 2–4 (PDE2–4), protein kinase A (PKA), protein phosphatases type 1 and 2A (PP1 and PP2A), G-protein receptor kinase type 2 (GRK2), heat-stable protein kinase inhibitor (PKI), and the inhibitor-1 (I-1). We found that the overexpression of AC5 resulted in an increased basal cAMP production, leading to an increased activation of PKA, prolongation of the action potential, and increased [Ca2+]i transient. Simulation results suggest blunted response of TG ventricular cells to the stimulation of β-adrenergic signaling system with isoproterenol comparing to wild type (WT) cells. Simulations of spontaneous Ca2+ release showed larger magnitudes of DADs in TG as compared to WT mice. Modeling data were compared to the experimental data obtained from TG mice overexpressing AC5 as well as to the simulations obtained with the mathematical model for WT mice.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Keys, J. R., & Koch, W. J. (2004). The adrenergic pathway and heart failure. Recent Progress in Hormone Research, 59, 13–30.
Koch, W. J., Lefkowitz, R. J., & Rockman, H. A. (2000). Functional consequences of altering myocardial adrenergic receptor signaling. Annual Review of Physiology, 62, 237–260.
Nerbonne, J. M. (2014). Mouse models of arrhythmogenic cardiovascular disease: Challenges and opportunities. Current Opinion in Pharmacology, 15, 107–114.
Brodde, O. E., & Michel, M. C. (1999). Adrenergic and muscarinic receptors in the human heart. Pharmacological Reviews, 51, 651–689.
Engelhardt, S., Hein, L., Wiesmann, F., & Lohse, M. J. (1999). Progressive hypertrophy and heart failure in β1-adrenergic receptor transgenic mice. Proceedings of the National Academy of Sciences of the United States of America, 96, 7059–7064.
Milano, C. A., Allen, L. F., Rockman, H. A., Dolber, P. C., McMinn, T. R., Chien, K. R., Johnson, T. D., Bond, R. A., & Lefkowitz, R. J. (1994). Enhanced myocardial function in transgenic mice overexpressing the β2-adrenergic receptor. Science, 264, 582–586.
Liggett, S. B., Tepe, N. M., Lorenz, J. N., Canning, A. M., Jantz, T. D., Mitarai, S., Yatani, A., & Dorn, G. W., II. (2000). Early and delayed consequences of β2-adrenergic receptor overexpression in mouse hearts. Critical role for expression level. Circulation, 101, 1707–1714.
Ho, D., Yan, L., Iwatsubo, K., Vatner, D. E., & Vatner, S. F. (2010). Modulation of β-adrenergic receptor signaling in heart failure and longevity: Targeting adenylyl cyclase type 5. Heart Failure Reviews, 15, 495–512.
Lai, L., Yan, L., Gao, S., Hu, C. L., Ge, H., Davidow, A., Park, M., Bravo, C., Iwatsubo, K., Ishikawa, Y., Auwerx, J., Sinclair, D. A., Vatner, S. F., & Vatner, D. E. (2013). Type 5 adenylyl cyclase increases oxidative stress by transcriptional regulation of manganese superoxide dismutase via the SIRT1/FoxO3a pathway. Circulation, 127, 1692–1701.
Vatner, S. F., Park, M., Yan, L., Lee, G. J., Lai, L., Iwatsubo, K., Ishikawa, Y., Pessin, J., & Vatner, D. E. (2013). Adenylyl cyclase 5 in cardiac disease, metabolism, and aging. American Journal of Physiology. Heart and Circulatory Physiology, 305, H1–H8.
Zhao, Z., Babu, G. J., Wen, H., Fefelova, N., Gordan, R., Sui, X., Yan, L., Vatner, D. E., Vatner, S. F., & Xie, L. H. (2015). Overexpression of adenylyl cyclase type 5 (AC5) confers a proarrhythmic substrate to the heart. American Journal of Physiology. Heart and Circulatory Physiology, 308, H240–H249.
Bondarenko, V. E. (2014). A compartmentalized mathematical model of the β1-adrenergic signaling system in mouse ventricular myocytes. PLoS One, 9, e89113.
Bondarenko, V. E., Szigeti, G. P., Bett, G. C. L., Kim, S. J., & Rasmusson, R. L. (2004). Computer model of action potential of mouse ventricular myocytes. American Journal of Physiology. Heart and Circulatory Physiology, 287, H1378–H1403.
Petkova-Kirova, P. S., London, B., Salama, G., Rasmusson, R. L., & Bondarenko, V. E. (2012). Mathematical modeling mechanisms of arrhythmias in transgenic mouse heart overexpressing TNF-α. American Journal of Physiology. Heart and Circulatory Physiology, 302, H934–H952.
Rozier, K., & Bondarenko, V. E. (2017). Distinct physiological effects of β1- and β2-adrenoceptors in mouse ventricular myocytes: Insights from a compartmentalized mathematical model. American Journal of Physiology. Cell Physiology, 312, C595–C623.
Tang, T., Lai, N. C., Roth, D. M., Drumm, J., Guo, T., Lee, K. W., Han, P. L., Dalton, N., & Gao, M. H. (2006). Adenylyl cyclase type V deletion increases basal left ventricular function and reduces left ventricular contractile responsiveness to β-adrenergic stimulation. Basic Research in Cardiology, 101, 117–126.
Luo, W., Grupp, I. L., Harrer, J., Ponniah, S., Grupp, G., Duffy, J. J., Doetschman, T., & Kranias, E. G. (1994). Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of β-agonist stimulation. Circulation Research, 75, 401–409.
Kadambi, V. J., Ponniah, S., Harrer, J. M., Hoit, B. D., Dorn, G. W., II, Walsh, R. A., & Kranias, E. G. (1996). Cardiac-specific overexpression of phospholamban alters calcium kinetics and resultant cardiomyocyte mechanics in transgenic mice. The Journal of Clinical Investigation, 97, 533–539.
Li, G. R., Feng, J., Wang, Z., Fermini, B., & Nattel, S. (1996). Adrenergic modulation of ultrarapid delayed rectifier K+ current in human atrial myocytes. Circulation Research, 78, 903–915.
Gaborit, N., Le Bouter, S., Szuts, V., Varro, A., Escande, D., Nattel, S., & Demolombe, S. (2007). Regional and tissue specific transcript signatures of ion channel genes in the non-diseased human heart. The Journal of Physiology, 582, 675–693.
Brandt, M. C., Priebe, L., Böhle, T., Südkamp, M., & Beuckelmann, D. J. (2000). The ultrarapid and the transient outward K+ current in human atrial fibrillation. Their possible role in postoperative atrial fibrillation. Journal of Molecular and Cellular Cardiology, 32, 1885–1896.
Kodirov, S. A., Brunner, M., Nerbonne, J. M., Buckett, P., Mitchell, G. F., & Koren, G. (2004). Attenuation of IK,slow1 and IK,slow2 in Kv1/Kv2DN mice prolongs APD and QT intervals but does not suppress spontaneous or inducible arrhythmias. American Journal of Physiology. Heart and Circulatory Physiology, 286, H368–H374.
London, B., Guo, W., Pan, X. H., Lee, J. S., Shusterman, V., Rocco, C. J., Logothetis, D. A., Nerbonne, J. M., & Hill, J. A. (2001). Targeted replacement of Kv1.5 in the mouse leads to loss of the 4-aminopyridine-sensitive component of IK,slow and resistance to drug-induced QT prolongation. Circulation Research, 88, 940–946.
Wilson, G. G., O’Neill, C. A., Sivaprasadarao, A., Findlay, J. B. C., & Wray, D. (1994). Modulation by protein kinase A of a cloned rat brain potassium channel expressed in Xenopus oocytes. Pflügers Archiv, 428, 186–193.
Zhou, M. H., Yang, G., Jiao, S., Hu, C. L., & Mei, Y. A. (2012). Cholesterol enhances neuron susceptibility to apoptotic stimuli via cAMP/PKA/CREb-dependent up-regulation of Kv2.1. Journal of Neurochemistry, 120, 502–514.
Tepe, N. M., & Liggett, S. B. (1999). Transgenic replacement of type V adenylyl cyclase identifies a critical mechanism of β-adrenergic receptor dysfunction in the Gαq overexpressing mouse. FEBS Letters, 458, 236–240.
Lemire, I., Allen, B. G., Rindt, H., & Hebert, T. E. (1998). Cardiac-specific overexpression of α1BAR regulates βAR activity via molecular crosstalk. Journal of Molecular and Cellular Cardiology, 30, 1827–1839.
Iwatsubo, K., Bravo, C., Uechi, M., Baljinnyam, E., Nakamura, T., Umemura, M., Lai, L., Gao, S., Yan, L., Zhao, X., Park, M., Qiu, H., Okumura, S., Iwatsubo, M., Vatner, D. E., Vatner, S. F., & Ishikawa, Y. (2012). Prevention of heart failure in mice by an antiviral agent that inhibits type 5 cardiac adenylyl cyclase. American Journal of Physiology. Heart and Circulatory Physiology, 302, H2622–H2628.
Nerbonne, J. M., Nichols, C. G., Schwarz, T. L., & Escande, D. (2001). Genetic manipulation of cardiac K+ channel function in mice: What have we learned, and where do we go from here? Circulation Research, 89, 944–956.
Guellich, A., Gao, S., Hong, C., Yan, L., Wagner, T. E., Dhar, S. K., Ghaleh, B., Hittinger, L., Iwatsubo, K., Ishikawa, Y., Vatner, S. F., & Vatner, D. E. (2010). Effects of cardiac overexpression of type 6 adenylyl cyclase affects on the response to chronic pressure overload. American Journal of Physiology. Heart and Circulatory Physiology, 299, H707–H712.
Gaudin, C., Ishikawa, Y., Wight, D. C., Mahdavi, V., Nadal-Ginard, B., Wagner, T. E., Vatner, D. E., & Homcy, C. J. (1995). Overexpression of Gsα protein in the hearts of transgenic mice. The Journal of Clinical Investigation, 95, 1676–1683.
Rozier, K., & Bondarenko, V. E. (2018). Mathematical modeling physiological effects of the overexpression of β2-adrenoceptors in mouse ventricular myocytes. American Journal of Physiology. Heart and Circulatory Physiology, 314, H643–H658.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Bondarenko, V.E. (2020). Mathematical Model of Mouse Ventricular Myocytes Overexpressing Adenylyl Cyclase Type 5. In: Zhao, Y., Chen, DG. (eds) Statistical Modeling in Biomedical Research. Emerging Topics in Statistics and Biostatistics . Springer, Cham. https://doi.org/10.1007/978-3-030-33416-1_16
Download citation
DOI: https://doi.org/10.1007/978-3-030-33416-1_16
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-33415-4
Online ISBN: 978-3-030-33416-1
eBook Packages: Mathematics and StatisticsMathematics and Statistics (R0)